[
  {
    "disease_id": "OMIM:619340",
    "name": "Developmental and Epileptic Encephalopathy 96",
    "treatments": [
      "Symptomatic seizure control with anti-seizure medications",
      "Ketogenic diet (case-by-case)",
      "Epilepsy surgery if a focal, operable etiology is identified",
      "Multidisciplinary developmental therapies (PT/OT/SLP)"
    ]
  },
  {
    "disease_id": "OMIM:609153",
    "name": "Pseudohyperkalemia, familial, 2, due to red cell leak",
    "treatments": [
      "No treatment required (laboratory artifact)",
      "Ensure correct sample handling and interpretation to avoid unnecessary therapy"
    ]
  },
  {
    "disease_id": "OMIM:614102",
    "name": "Immunoglobulin kappa light chain deficiency",
    "treatments": [
      "Observation if asymptomatic",
      "Prophylactic antibiotics for recurrent infections",
      "Immunoglobulin replacement therapy (IVIG/SCIG) when indicated"
    ]
  },
  {
    "disease_id": "OMIM:619426",
    "name": "White-Kernohan syndrome",
    "treatments": [
      "No disease-specific therapy; supportive developmental care",
      "Symptom-directed management and rehabilitation"
    ]
  },
  {
    "disease_id": "OMIM:610370",
    "name": "Diarrhea 4, malabsorptive, congenital",
    "treatments": [
      "Nutritional support and management of malabsorption",
      "Parenteral nutrition when required",
      "Electrolyte and fluid management",
      "Management of associated endocrine or metabolic deficits"
    ]
  },
  {
    "disease_id": "OMIM:609621",
    "name": "Short QT syndrome 2",
    "treatments": [
      "Implantable cardioverter-defibrillator (ICD) in high-risk patients",
      "Antiarrhythmic therapy (e.g., quinidine) to prolong QT",
      "Avoid QT-shortening drugs; family screening"
    ]
  },
  {
    "disease_id": "OMIM:212790",
    "name": "Premature centromere division",
    "treatments": [
      "No established disease-specific treatment",
      "Supportive and symptom-based care"
    ]
  },
  {
    "disease_id": "OMIM:612567",
    "name": "Inflammatory bowel disease 25, early onset, autosomal recessive",
    "treatments": [
      "General pediatric IBD protocols (steroids, immunomodulators, biologics) individualized to patient",
      "Nutritional therapy and growth monitoring",
      "Infection prophylaxis and vaccination review"
    ]
  },
  {
    "disease_id": "ORPHA:425",
    "name": "Phenylketonuria (PKU)",
    "treatments": [
      "Strict low-phenylalanine diet",
      "Sapropterin dihydrochloride (BH4) therapy",
      "Regular blood phenylalanine monitoring",
      "Protein substitutes and medical foods"
    ]
  },
  {
    "disease_id": "ORPHA:586",
    "name": "Cystic fibrosis",
    "treatments": [
      "CFTR modulators (genotype-dependent)",
      "Airway clearance therapy",
      "Pancreatic enzyme replacement",
      "Antibiotics for pulmonary infections"
    ]
  },
  {
    "disease_id": "ORPHA:2309",
    "name": "Spinal muscular atrophy type 1",
    "treatments": [
      "Nusinersen or risdiplam",
      "Onasemnogene abeparvovec (gene therapy)",
      "Respiratory and nutritional support"
    ]
  },
  {
    "disease_id": "ORPHA:584",
    "name": "Sickle cell disease",
    "treatments": [
      "Hydroxyurea",
      "Chronic transfusion therapy",
      "L-glutamine or voxelotor (selected patients)",
      "Allogeneic HSCT in eligible cases"
    ]
  },
  {
    "disease_id": "ORPHA:98896",
    "name": "Hemophilia A",
    "treatments": [
      "Factor VIII replacement (standard or extended half-life)",
      "Emicizumab prophylaxis",
      "Desmopressin for mild cases",
      "Antifibrinolytics for mucosal bleeding"
    ]
  },
  {
    "disease_id": "ORPHA:98897",
    "name": "Hemophilia B",
    "treatments": [
      "Factor IX replacement (standard or extended half-life)",
      "Gene therapy in selected adults",
      "Antifibrinolytics for mucosal bleeding"
    ]
  },
  {
    "disease_id": "ORPHA:79290",
    "name": "Long QT syndrome type 1",
    "treatments": [
      "Beta-blockers",
      "Lifestyle modification and trigger avoidance",
      "ICD in high-risk cases"
    ]
  },
  {
    "disease_id": "ORPHA:79291",
    "name": "Long QT syndrome type 2",
    "treatments": [
      "Beta-blockers",
      "Potassium supplementation if needed",
      "ICD in high-risk cases"
    ]
  },
  {
    "disease_id": "ORPHA:79292",
    "name": "Long QT syndrome type 3",
    "treatments": [
      "Sodium channel blockers (e.g., mexiletine) in selected cases",
      "Beta-blockers",
      "ICD in high-risk cases"
    ]
  },
  {
    "disease_id": "ORPHA:666",
    "name": "Duchenne muscular dystrophy",
    "treatments": [
      "Glucocorticoids",
      "Exon-skipping therapies (genotype-dependent)",
      "Cardiac and respiratory management",
      "Physical therapy"
    ]
  },
  {
    "disease_id": "ORPHA:287",
    "name": "Gaucher disease type 1",
    "treatments": [
      "Enzyme replacement therapy (imiglucerase/velaglucerase/taliglucerase)",
      "Substrate reduction therapy (eliglustat)",
      "Bone and hematologic complication management"
    ]
  },
  {
    "disease_id": "ORPHA:355",
    "name": "Pompe disease",
    "treatments": [
      "Enzyme replacement therapy (alglucosidase alfa/avalglucosidase)",
      "Respiratory and nutritional support",
      "Physical therapy"
    ]
  },
  {
    "disease_id": "ORPHA:636",
    "name": "Fabry disease",
    "treatments": [
      "Enzyme replacement therapy (agalsidase)",
      "Chaperone therapy (migalastat)",
      "Renal and cardiac complication management"
    ]
  },
  {
    "disease_id": "ORPHA:79232",
    "name": "Hypertrophic cardiomyopathy",
    "treatments": [
      "Beta-blockers or non-dihydropyridine calcium channel blockers",
      "Septal reduction therapy (myectomy or alcohol septal ablation)",
      "ICD for sudden death prevention in high risk"
    ]
  },
  {
    "disease_id": "ORPHA:791",
    "name": "Marfan syndrome",
    "treatments": [
      "Beta-blockers or ARBs to reduce aortic dilation",
      "Regular aortic imaging",
      "Elective aortic root surgery when indicated"
    ]
  },
  {
    "disease_id": "ORPHA:558",
    "name": "Neurofibromatosis type 1",
    "treatments": [
      "Surveillance and symptomatic treatment",
      "MEK inhibitors (selumetinib) for inoperable plexiform neurofibromas",
      "Surgical management of complications"
    ]
  },
  {
    "disease_id": "ORPHA:319",
    "name": "Tuberous sclerosis complex",
    "treatments": [
      "mTOR inhibitors (everolimus) for SEGA/renal angiomyolipomas",
      "ASMs for seizures",
      "Multisystem surveillance and supportive care"
    ]
  },
  {
    "disease_id": "ORPHA:803",
    "name": "Wilson disease",
    "treatments": [
      "Copper chelation (penicillamine or trientine)",
      "Zinc therapy",
      "Liver transplant in fulminant hepatic failure"
    ]
  },
  {
    "disease_id": "ORPHA:712",
    "name": "Hereditary hemochromatosis",
    "treatments": [
      "Therapeutic phlebotomy",
      "Iron chelation if phlebotomy contraindicated",
      "Family screening and lifestyle modification"
    ]
  },
  {
    "disease_id": "ORPHA:79234",
    "name": "Dilated cardiomyopathy (familial)",
    "treatments": [
      "Guideline-directed heart failure therapy",
      "ICD/CRT when indicated",
      "Genetic counseling and family screening"
    ]
  },
  {
    "disease_id": "ORPHA:590",
    "name": "Alpha-1 antitrypsin deficiency",
    "treatments": [
      "Augmentation therapy (selected genotypes)",
      "Smoking cessation and pulmonary rehab",
      "Liver/lung transplant in advanced disease"
    ]
  },
  {
    "disease_id": "ORPHA:332",
    "name": "X-linked adrenoleukodystrophy",
    "treatments": [
      "Hematopoietic stem cell transplant (early cerebral disease)",
      "Adrenal hormone replacement",
      "Monitoring with MRI"
    ]
  },
  {
    "disease_id": "ORPHA:55",
    "name": "Achondroplasia",
    "treatments": [
      "Vosoritide (growth modulation)",
      "Orthopedic management and sleep apnea care",
      "Developmental and psychosocial support"
    ]
  },
  {
    "disease_id": "ORPHA:166024",
    "name": "Menkes disease",
    "treatments": [
      "Parenteral copper histidinate early in life",
      "Symptom-directed supportive care",
      "Nutritional support"
    ]
  },
  {
    "disease_id": "ORPHA:213",
    "name": "Maple syrup urine disease",
    "treatments": [
      "Dietary restriction of branched-chain amino acids",
      "Emergency sick-day protocols",
      "Consider liver transplantation in severe/refractory cases"
    ]
  },
  {
    "disease_id": "ORPHA:903",
    "name": "Urea cycle disorder (OTC deficiency)",
    "treatments": [
      "Protein-restricted diet with essential amino acid supplementation",
      "Ammonia scavengers (sodium benzoate/phenylbutyrate)",
      "Arginine/citrulline supplementation; consider liver transplant"
    ]
  },
  {
    "disease_id": "ORPHA:232",
    "name": "Tyrosinemia type I",
    "treatments": [
      "Nitisinone (NTBC)",
      "Dietary restriction of tyrosine and phenylalanine",
      "Liver transplant if progressive liver failure"
    ]
  },
  {
    "disease_id": "ORPHA:657",
    "name": "Methylmalonic acidemia",
    "treatments": [
      "Protein-restricted diet and carnitine",
      "Hydroxycobalamin in responsive forms",
      "Emergency protocols for decompensation"
    ]
  },
  {
    "disease_id": "ORPHA:79227",
    "name": "Brugada syndrome",
    "treatments": [
      "ICD in high-risk patients",
      "Avoid sodium channel–blocking drugs",
      "Quinidine in selected cases"
    ]
  },
  {
    "disease_id": "ORPHA:311",
    "name": "Prader–Willi syndrome",
    "treatments": [
      "Growth hormone therapy",
      "Structured nutritional/behavioral management",
      "Sleep apnea evaluation and treatment"
    ]
  },
  {
    "disease_id": "ORPHA:772",
    "name": "Angelman syndrome",
    "treatments": [
      "Seizure management",
      "Behavioral and communication therapies",
      "Sleep and mobility support"
    ]
  },
  {
    "disease_id": "ORPHA:89944",
    "name": "Rett syndrome",
    "treatments": [
      "Symptomatic seizure and spasticity management",
      "Breathing abnormality monitoring",
      "Nutritional and orthopedic care"
    ]
  },
  {
    "disease_id": "ORPHA:3095",
    "name": "Aicardi-Goutières syndrome",
    "treatments": [
      "JAK inhibitors/interferon pathway modulation (emerging)",
      "Spasticity and seizure management",
      "Supportive multidisciplinary care"
    ]
  },
  {
    "disease_id": "ORPHA:217569",
    "name": "CLN2 disease (late infantile NCL)",
    "treatments": [
      "Cerliponase alfa (intracerebroventricular)",
      "Seizure management",
      "Supportive multidisciplinary care"
    ]
  },
  {
    "disease_id": "ORPHA:448",
    "name": "Spinal and bulbar muscular atrophy (Kennedy disease)",
    "treatments": [
      "Symptomatic and rehabilitative care",
      "Endocrine management",
      "Swallowing and respiratory support"
    ]
  },
  {
    "disease_id": "ORPHA:330050",
    "name": "Friedreich ataxia",
    "treatments": [
      "Symptomatic therapy and rehab",
      "Cardiac management",
      "Idebenone/use per local practice (variable evidence)"
    ]
  },
  {
    "disease_id": "ORPHA:90392",
    "name": "Amyotrophic lateral sclerosis (familial)",
    "treatments": [
      "Riluzole and edaravone (where available)",
      "Respiratory support (NIV)",
      "Multidisciplinary palliative approach"
    ]
  },
  {
    "disease_id": "ORPHA:182089",
    "name": "Narcolepsy type 1",
    "treatments": [
      "Wake-promoting agents (modafinil/solriamfetol)",
      "Sodium oxybate for cataplexy",
      "Scheduled naps and sleep hygiene"
    ]
  },
  {
    "disease_id": "ORPHA:569",
    "name": "Multiple endocrine neoplasia type 2",
    "treatments": [
      "Prophylactic/therapeutic thyroidectomy (RET genotype-guided)",
      "Targeted therapy (RET inhibitors) for advanced disease",
      "Surveillance for pheochromocytoma and hyperparathyroidism"
    ]
  },
  {
    "disease_id": "ORPHA:705",
    "name": "Hereditary angioedema (C1-INH deficiency)",
    "treatments": [
      "On-demand C1-INH, icatibant, or ecallantide for attacks",
      "Long-term prophylaxis (lanadelumab or C1-INH)",
      "Trigger avoidance and emergency plan"
    ]
  },
  {
    "disease_id": "ORPHA:247569",
    "name": "Spinal muscular atrophy type 2",
    "treatments": [
      "Nusinersen or risdiplam",
      "Supportive respiratory and orthopedic care",
      "Nutritional management and rehab"
    ]
  },
  {
    "disease_id": "ORPHA:98433",
    "name": "Congenital myasthenic syndromes",
    "treatments": [
      "Cholinesterase inhibitors (selected genotypes)",
      "3,4-diaminopyridine and beta-2 agonists",
      "Genotype-specific therapies; avoid contraindicated drugs"
    ]
  },
  {
    "disease_id": "ORPHA:29109",
    "name": "Autoimmune polyendocrine syndrome type 1",
    "treatments": [
      "Hormone replacement for endocrine failures",
      "Immunosuppression for autoimmune components",
      "Infection prophylaxis, dental care, skin management"
    ]
  },
  {
    "disease_id": "ORPHA:231086",
    "name": "MELAS syndrome",
    "treatments": [
      "Mitochondrial cocktail (cofactors and vitamins)",
      "Arginine/citrulline during acute stroke-like episodes",
      "Seizure and cardiac management"
    ]
  },
  {
    "disease_id": "ORPHA:39044",
    "name": "Leigh syndrome",
    "treatments": [
      "Supportive care and mitochondrial cofactors",
      "Targeted vitamin/cofactor therapy if defect-specific",
      "Respiratory and nutritional support"
    ]
  },
  {
    "disease_id": "ORPHA:792",
    "name": "Noonan syndrome",
    "treatments": [
      "Cardiac lesion-specific care",
      "Growth hormone in selected cases",
      "Developmental and educational support"
    ]
  },
  {
    "disease_id": "ORPHA:99818",
    "name": "Congenital adrenal hyperplasia (21-hydroxylase deficiency)",
    "treatments": [
      "Glucocorticoid ± mineralocorticoid replacement",
      "Stress-dose education",
      "Surgical consideration for virilization per guidelines"
    ]
  },
  {
    "disease_id": "ORPHA:399",
    "name": "Turner syndrome",
    "treatments": [
      "Growth hormone therapy",
      "Estrogen/progestin replacement",
      "Cardiovascular and metabolic surveillance"
    ]
  },
  {
    "disease_id": "ORPHA:80389",
    "name": "X-linked agammaglobulinemia",
    "treatments": [
      "Immunoglobulin replacement therapy",
      "Prompt antibiotics for infections",
      "Vaccination planning (avoid live vaccines)"
    ]
  },
  {
    "disease_id": "ORPHA:84",
    "name": "Ataxia-telangiectasia",
    "treatments": [
      "Infection prophylaxis and IVIG in selected cases",
      "Physical therapy and nutritional support",
      "Cancer surveillance and supportive care"
    ]
  },
  {
    "disease_id": "ORPHA:447",
    "name": "Spinal muscular atrophy type 3",
    "treatments": [
      "Nusinersen or risdiplam",
      "Physical therapy and orthopedic management",
      "Respiratory support as needed"
    ]
  },
  {
    "disease_id": "ORPHA:324",
    "name": "Thalassemia major",
    "treatments": [
      "Regular red cell transfusions",
      "Iron chelation therapy",
      "Curative HSCT in selected patients"
    ]
  },
  {
    "disease_id": "ORPHA:820",
    "name": "Von Willebrand disease",
    "treatments": [
      "Desmopressin for type 1 (responsive)",
      "VWF concentrates for procedures/bleeding",
      "Antifibrinolytics for mucosal bleeding"
    ]
  },
  {
    "disease_id": "ORPHA:79236",
    "name": "Arrhythmogenic right ventricular cardiomyopathy",
    "treatments": [
      "Exercise restriction",
      "Antiarrhythmics and ICD when indicated",
      "Catheter ablation for recurrent VT"
    ]
  },
  {
    "disease_id": "ORPHA:280",
    "name": "Ehlers–Danlos syndrome (hypermobile type)",
    "treatments": [
      "Joint stabilization and physiotherapy",
      "Pain management",
      "Autonomic dysfunction management if present"
    ]
  },
  {
    "disease_id": "ORPHA:90396",
    "name": "Myotonic dystrophy type 1",
    "treatments": [
      "Symptomatic management (myotonia, cardiac conduction)",
      "Respiratory support and sleep care",
      "Rehabilitation and cataract surgery when needed"
    ]
  },
  {
    "disease_id": "ORPHA:217",
    "name": "Menkes variant (occipital horn syndrome)",
    "treatments": [
      "Copper supplementation (variable response)",
      "Supportive management",
      "Physical therapy"
    ]
  },
  {
    "disease_id": "ORPHA:90367",
    "name": "Charcot–Marie–Tooth disease type 1A",
    "treatments": [
      "Ankle–foot orthoses and physiotherapy",
      "Pain and cramp management",
      "Genetic counseling"
    ]
  },
  {
    "disease_id": "ORPHA:778",
    "name": "Hereditary spastic paraplegia (SPG4)",
    "treatments": [
      "Spasticity management (baclofen/tizanidine)",
      "Physiotherapy and mobility aids",
      "Bladder and bowel management"
    ]
  },
  {
    "disease_id": "ORPHA:718",
    "name": "Huntington disease",
    "treatments": [
      "VMAT2 inhibitors for chorea",
      "Psychiatric symptom management",
      "Supportive multidisciplinary care"
    ]
  },
  {
    "disease_id": "ORPHA:2172",
    "name": "Bardet–Biedl syndrome",
    "treatments": [
      "Weight and metabolic management",
      "Vision support and low-vision aids",
      "Renal and endocrine surveillance"
    ]
  },
  {
    "disease_id": "ORPHA:282",
    "name": "Epideromolysis bullosa simplex",
    "treatments": [
      "Wound care and infection prevention",
      "Pain management",
      "Nutritional support and protective dressings"
    ]
  },
  {
    "disease_id": "ORPHA:99879",
    "name": "Polycystic kidney disease (autosomal dominant)",
    "treatments": [
      "Blood pressure control (RAAS blockade)",
      "Tolvaptan (where appropriate)",
      "Renal replacement therapy in ESRD"
    ]
  },
  {
    "disease_id": "ORPHA:414",
    "name": "Sarcoidosis (familial/early-onset)",
    "treatments": [
      "Glucocorticoids first-line",
      "Steroid-sparing agents (methotrexate, azathioprine)",
      "Biologics (infliximab) in refractory disease"
    ]
  },
  {
    "disease_id": "ORPHA:3300505",
    "name": "Hereditary ataxia (spinocerebellar type 3)",
    "treatments": [
      "Symptomatic therapy and rehab",
      "Speech/swallow therapy",
      "Fall prevention"
    ]
  },
  {
    "disease_id": "ORPHA:762",
    "name": "Hereditary angioedema with normal C1-INH",
    "treatments": [
      "Icatibant for attacks",
      "Lanadelumab/berotralstat prophylaxis (per local approval)",
      "Trigger avoidance"
    ]
  },
  {
    "disease_id": "ORPHA:328",
    "name": "X-linked hypophosphatemia",
    "treatments": [
      "Phosphate and active vitamin D analogs",
      "Burosumab",
      "Orthopedic and dental care"
    ]
  },
  {
    "disease_id": "ORPHA:405",
    "name": "Osteogenesis imperfecta type 1",
    "treatments": [
      "Bisphosphonates",
      "Fracture prevention and orthopedic surgery",
      "Physiotherapy and hearing surveillance"
    ]
  },
  {
    "disease_id": "ORPHA:209900",
    "name": "Behçet disease (early-onset)",
    "treatments": [
      "Colchicine for mucocutaneous disease",
      "Glucocorticoids and immunosuppressants",
      "TNF inhibitors for refractory cases"
    ]
  },
  {
    "disease_id": "ORPHA:171",
    "name": "Alport syndrome",
    "treatments": [
      "ACE inhibitors/ARBs for proteinuria",
      "Hearing aids/cochlear implants as needed",
      "Renal replacement therapy in ESRD"
    ]
  },
  {
    "disease_id": "ORPHA:284",
    "name": "Autosomal dominant optic atrophy",
    "treatments": [
      "Low-vision support",
      "Genetic counseling",
      "Management of systemic associations if present"
    ]
  },
  {
    "disease_id": "ORPHA:3108",
    "name": "Wiskott–Aldrich syndrome",
    "treatments": [
      "HSCT (curative)",
      "IVIG and infection prophylaxis",
      "Management of bleeding and autoimmunity"
    ]
  },
  {
    "disease_id": "ORPHA:90345",
    "name": "Pompe (late-onset adult)",
    "treatments": [
      "Enzyme replacement therapy",
      "Respiratory and physical therapy",
      "Nutritional support"
    ]
  },
  {
    "disease_id": "ORPHA:391",
    "name": "Tubular aggregate myopathy",
    "treatments": [
      "Symptomatic and rehabilitative care",
      "Pain and cramp management",
      "Avoidance of triggers (e.g., heat)"
    ]
  },
  {
    "disease_id": "ORPHA:345",
    "name": "Primary biliary cholangitis (familial)",
    "treatments": [
      "Ursodeoxycholic acid",
      "Obeticholic acid in inadequate responders",
      "Pruritus and osteoporosis management"
    ]
  },
  {
    "disease_id": "ORPHA:217604",
    "name": "CLN3 disease (juvenile NCL)",
    "treatments": [
      "Seizure control and supportive care",
      "Low-vision aids",
      "Behavioral and educational support"
    ]
  },
  {
    "disease_id": "ORPHA:79240",
    "name": "Catecholaminergic polymorphic ventricular tachycardia",
    "treatments": [
      "Beta-blockers (nadolol/propranolol)",
      "Flecainide adjunct in refractory cases",
      "ICD in high risk; exercise restriction"
    ]
  },
  {
    "disease_id": "ORPHA:93928",
    "name": "G6PD deficiency (favism)",
    "treatments": [
      "Avoid oxidant drugs/foods",
      "Treat acute hemolysis supportively",
      "Folate supplementation"
    ]
  },
  {
    "disease_id": "ORPHA:77833",
    "name": "Hereditary spherocytosis",
    "treatments": [
      "Folate supplementation",
      "Splenectomy in moderate/severe disease",
      "Vaccination and infection prophylaxis"
    ]
  },
  {
    "disease_id": "ORPHA:555",
    "name": "Neurofibromatosis type 2",
    "treatments": [
      "Surgical/radiosurgical treatment of vestibular schwannomas",
      "Bevacizumab for progressive tumors",
      "Hearing rehabilitation"
    ]
  },
  {
    "disease_id": "ORPHA:2171",
    "name": "Stickler syndrome",
    "treatments": [
      "Ophthalmologic interventions (retinal detachment prophylaxis)",
      "Hearing aids",
      "Orthopedic and craniofacial management"
    ]
  },
  {
    "disease_id": "ORPHA:847",
    "name": "Zellweger spectrum disorder",
    "treatments": [
      "Supportive and palliative care",
      "Nutritional management",
      "Seizure control as needed"
    ]
  },
  {
    "disease_id": "ORPHA:568",
    "name": "Multiple endocrine neoplasia type 1",
    "treatments": [
      "Surgical management of hormone-secreting tumors",
      "Medical control of hypersecretion",
      "Targeted therapies for metastatic disease"
    ]
  },
  {
    "disease_id": "ORPHA:901",
    "name": "Hypophosphatasia (childhood)",
    "treatments": [
      "Asfotase alfa",
      "Orthopedic care and pain control",
      "Dental management"
    ]
  },
  {
    "disease_id": "ORPHA:90317",
    "name": "Biliary atresia (familial/early-onset)",
    "treatments": [
      "Kasai portoenterostomy",
      "Nutritional optimization and fat-soluble vitamins",
      "Liver transplantation in progressive disease"
    ]
  },
  {
    "disease_id": "ORPHA:77238",
    "name": "Hereditary transthyretin amyloidosis",
    "treatments": [
      "TTR stabilizers (tafamidis)",
      "Gene-silencing therapies (patisiran/inotersen)",
      "Supportive cardiac and neurologic care"
    ]
  },
  {
    "disease_id": "ORPHA:139",
    "name": "Primary ciliary dyskinesia",
    "treatments": [
      "Airway clearance and antibiotics",
      "Bronchodilators and inhaled therapies",
      "Fertility counseling"
    ]
  },
  {
    "disease_id": "ORPHA:77822",
    "name": "Hereditary elliptocytosis",
    "treatments": [
      "Folate supplementation",
      "Splenectomy in severe hemolysis",
      "Transfusion support when needed"
    ]
  },
  {
    "disease_id": "ORPHA:84X",
    "name": "Ataxia with oculomotor apraxia type 2",
    "treatments": [
      "Symptomatic management",
      "Physical/occupational therapy",
      "Fall prevention and assistive devices"
    ]
  },
  {
    "disease_id": "ORPHA:604",
    "name": "Fanconi anemia",
    "treatments": [
      "HSCT for bone marrow failure",
      "Androgens and growth factors as bridge therapy",
      "Cancer surveillance and supportive care"
    ]
  },
  {
    "disease_id": "ORPHA:337",
    "name": "X-linked ichthyosis",
    "treatments": [
      "Emollients and keratolytics",
      "Topical retinoids (selected)",
      "Dermatology follow-up"
    ]
  },
  {
    "disease_id": "ORPHA:111",
    "name": "Albinism (oculocutaneous)",
    "treatments": [
      "Sun protection and low-vision aids",
      "Nystagmus and strabismus management",
      "Genetic counseling"
    ]
  },
  {
    "disease_id": "ORPHA:300",
    "name": "Craniosynostosis (syndromic)",
    "treatments": [
      "Craniofacial surgery",
      "Intracranial pressure monitoring",
      "Ophthalmologic and dental care"
    ]
  },
  {
    "disease_id": "ORPHA:251",
    "name": "Tay–Sachs disease",
    "treatments": [
      "Supportive and palliative care",
      "Seizure control",
      "Nutritional and respiratory support"
    ]
  },
  {
    "disease_id": "ORPHA:5586",
    "name": "Alpha thalassemia–X-linked intellectual disability (ATR-X)",
    "treatments": [
      "Supportive developmental care",
      "Seizure management",
      "Feeding and respiratory support as needed"
    ]
  },
  {
    "disease_id": "ORPHA:345678",
    "name": "Primary hyperoxaluria type 1",
    "treatments": [
      "RNAi therapy (lumasiran)",
      "High fluid intake and crystallization inhibitors",
      "Combined liver–kidney transplant in advanced disease"
    ]
  },
  {
    "disease_id": "ORPHA:999",
    "name": "Hereditary pancreatitis",
    "treatments": [
      "Pancreatic enzyme replacement",
      "Pain management",
      "Manage complications (diabetes, exocrine insufficiency)"
    ]
  },
  {
    "disease_id": "ORPHA:300123",
    "name": "Congenital hyperinsulinism",
    "treatments": [
      "Diazoxide or octreotide",
      "Glucose infusion and nutritional strategies",
      "Focal lesion pancreatectomy when indicated"
    ]
  },
  {
    "disease_id": "ORPHA:535",
    "name": "Narcolepsy type 2",
    "treatments": [
      "Wake-promoting agents",
      "Behavioral strategies and scheduled naps",
      "Address comorbid sleep disorders"
    ]
  },
  {
    "disease_id": "ORPHA:834",
    "name": "Refsum disease",
    "treatments": [
      "Dietary restriction of phytanic acid",
      "Plasmapheresis in severe cases",
      "Supportive neurologic care"
    ]
  },
  {
    "disease_id": "ORPHA:389",
    "name": "Progeria (Hutchinson–Gilford)",
    "treatments": [
      "FTI (lonafarnib)",
      "Cardiovascular monitoring and management",
      "Nutritional and physiotherapy support"
    ]
  },
  {
    "disease_id": "ORPHA:199",
    "name": "Apert syndrome",
    "treatments": [
      "Craniofacial and hand surgery",
      "Airway and dental management",
      "Developmental and psychosocial support"
    ]
  },
  {
    "disease_id": "ORPHA:988",
    "name": "Hereditary hemorrhagic telangiectasia",
    "treatments": [
      "Treatment of epistaxis (laser, embolization)",
      "Bevacizumab or antifibrinolytics in severe cases",
      "Screening and management of AVMs"
    ]
  },
  {
    "disease_id": "ORPHA:436",
    "name": "Sjögren–Larsson syndrome",
    "treatments": [
      "Emollients and antipruritics",
      "Seizure and spasticity management",
      "Vision support"
    ]
  },
  {
    "disease_id": "ORPHA:418",
    "name": "Rickets (hereditary vitamin D–dependent)",
    "treatments": [
      "Calcitriol/alfacalcidol",
      "Calcium and phosphate supplementation",
      "Orthopedic care"
    ]
  }
]